
0:00
8:42
Tam Maiuri, MaryAnn Emerick, and Allison Bartlett touch base on uniQure’s announcement that the FDA has accepted its application for AMT-130 and granted Priority Review, with a target action date of May 1, 2027. Join them for a brief conversation about this latest development for the Huntington’s disease community.
Don't forget to follow us on social media!
Weitere Episoden von „The HDSA Podcast“



Verpasse keine Episode von “The HDSA Podcast” und abonniere ihn in der kostenlosen GetPodcast App.








